Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

10 Years of Athena Swan

Athena Swan recognises a department’s commitment to gender equality, to understanding their own culture and context, to engaging with their communities and to committing to detailed and ambitious action plans in response to data and consultation.

NDORMS submitted an application for the Athena Swan Bronze Award in November 2013, and achieved this in 2014.

In 2015 NDORMS submitted and achieved the application for the Athena Swan Silver Award, which was renewed in 2018.

There are many initiatives within NDORMS that have helped us to achieve the Silver Award, and lots of people that have helped us to get there.


NDORMS Mediation Service

In 2022 we launched an internal Mediation Service. Led by Maria Granell Moreno and Isuara Thomas, the service helps to informally manage workplace conflicts and learn from them. The Mediation Service is open to staff and students who find themselves in conflict with another member of staff or student, and provides a confidential space and a chance to voice feelings and hear things from the other person’s perspective. 

Mediation helps to improve our working environment and research culture by empowering individuals and teams to manage their conflicts efficiently, informally and constructively.

NDORMS will share the progress of the Mediation Service with the wider University and will potentially help to launch this in other departments.

Find out more about the Mediation Service.  



The Taught MSc in Musculoskeletal Sciences is a part-time two-year course integrating orthopaedics and rheumatology. The vision is to train the future leaders in the field of musculoskeletal sciences. 

In 2017 Professor Steph Dakin was appointed as the Director of Graduate Studies for the course. Since then, we have increased our efforts to balance the gender ratio and attract more female candidates to the course. 

Taught MSc infographic

Working with the Communications Team, we have used social media to reach potential female students. We also ensure that women are represented on the course. The Course Director is female, as are several members of the Organising Committee, and we strive to have 50% on-course teaching materials contributed by women. 

Find out more about the Taught MSc.

Similar stories

£1.2M to improve diagnosis of emergency spinal condition

The National Institute for Health and Care Research has awarded an Advanced Fellowship to Dr David Metcalfe to study the diagnosis of the spinal condition, cauda equina syndrome.

Professor Chris Lavy appointed to WHO technical advisory group

Congratulations to Professor Chris Lavy, who has been appointed to the World Health Organization’s (WHO) technical advisory group for integrated clinical care for a period of two years.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Gene variant links trigger finger and carpal tunnel syndrome

A new NDORMS study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.

Kennedy programmes support early career researchers

Since 2013 the Kennedy Institute of Rheumatology has been running a Career Development Programme, a scheme to help early career researchers launch their own independent laboratories, and more recently the Innovator Investigator Programme to bring new technologies to core research themes.

OCTRU collaboration boosts understanding of COVID vaccine response

Working with researchers across multiple universities, the Oxford Clinical Trials Unit (OCTRU) played a key role in delivering results of the national VROOM trial (Vaccine Response On Off Methotrexate).